<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57070">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01976533</url>
  </required_header>
  <id_info>
    <org_study_id>3-3013-144/1/</org_study_id>
    <nct_id>NCT01976533</nct_id>
  </id_info>
  <brief_title>Eisenmenger Syndrome in the Nordic Countries</brief_title>
  <official_title>Eisenmenger Syndrome in the Nordic Countries: Advanced Treatment and Mortality 1977-2012</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rikshospitalet University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital for Children and Adolescents, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Actelion</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <authority>Finland: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a historical cohort study with retrospective collection of data comprising all
      Nordic patient's diagnosed with Eisenmengers syndrome in the period 1977 through 2011. The
      goal is to determine prognostic factors for mortality and morbidity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The following variables are obtained from national registries for each individual fulfilling
      the inclusion criteria:

        -  Personal data: Gender, day of birth, vital status (dead/alive), date of death, cause of
           death, all cause hospitalization days

        -  Specific cardiac malformation diagnosis

        -  Heart-lung transplantation.

        -  Social data: Highest educational level, marital status, employment status (Denmark
           only)

      Primary endpoints

        -  Incidence and prevalence of Eisenmenger Syndrome

        -  All-cause mortality

        -  All-cause morbidity (hospitalization for any cause)

        -  Heart-lung transplantation

        -  Advanced treatment

        -  Mortality with AT

        -  Highest educational level

        -  Personal income

        -  Marital status

        -  Job status
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Eisenmenger Syndrome</condition>
  <arm_group>
    <arm_group_label>Advanced therapy, Heart-lung transplantation, dead</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Nordic patients with Eisnemnger syndrome
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eisenmenger syndrome

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Soendergaard, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cristel Soerensen, MD</last_name>
    <email>cristel@dadlnet.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dept. Cardiology B, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristel Soerensen, MD</last_name>
      <email>cristel@dadlnet.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centers for Adult Congenital Heart Disease</name>
      <address>
        <city>Various</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centers for Adult Congenital Heart Disease</name>
      <address>
        <city>Various</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centers for adult congenital heart disease</name>
      <address>
        <city>Various</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Finland</country>
    <country>Norway</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 29, 2013</lastchanged_date>
  <firstreceived_date>October 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Cristel SÃ¸rensen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Eisenmenger Complex</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
